# Dexamethasone

## Dexamethasone inj 5mg/1mL

| TAH Drug Code      | [IDEXA](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IDEXA)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Conditions where the anti-inflammatory & immunosuppressive effects of the corticosteroids are desirable, especially for intensive treatment during shorter periods.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Dosing             | IM and IV: 2-10 mg (0.4-2 mL). INS : 4-6 mg (0.8-1.2 mL) on large joint and 0.8-1 mg (0.16-0.2 mL) for smaller joint. Soft tissue: 2-6 mg (0.4-1.2 mL). Subconjectival or retrobulbar injection: 0.4-2 mg (0.08-0.4 mL). ID: diluted 1/5 of Dexamethasone with normal saline, then inject 0.1mL. Eye drops: diluted 1/25 of Dexamethasone with normal saline.                                                                                                                                                                                                                                                                                           |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Contraindications  | Systemic fungal infection, hypersensitivity. Administration of live virus vaccine, unstable or infected joint, diagnosed sepsis.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Adverse Effects    | Common: Body fluid retention, Hypertension, Skin irritation, Cushing's syndrome, Decreased body growth, Depression, Euphoria, Pulmonary tuberculosis Serious: Cardiac rupture due to and following acute myocardial infarction, Cardiomyopathy, Thromboembolic disorder, Hyperglycemia, Pancreatitis, Perforation of large intestine, Perforation of small intestine, Non-allergic anaphylaxis, Compression fracture of vertebral column, Osteoporosis, Cerebrovascular accident, Infarction of spinal cord, Nerve injury, Paraplegia, Raised intracranial pressure, Seizure, Tetraplegia, Blindness AND/OR vision impairment level, Cortical blindness |
| Pregnancy          | Compatible â€“ Maternal Benefit >> Embryo-Fetal Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |

## Dorison 4mg

| TAH Drug Code      | [ODOR4](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ODOR4)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Conditions where the anti-inflammatory and immunosuppressive effects of the corticosteroids are desirable, especially for intensive treatment during shorter periods.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Dosing             | Parkinson's disease: Adult: Monotherapy, 100 mg orally twice daily; may titrate up to 400 mg/day in divided doses. During a serious related disease or receiving high-dose anti-Parkinson's disease treatment, the initial dose of this agent is 100 mg once a day, After 1-7 weeks, if necessary, may titrate up to 100 mg twice a day; and additionally up to 400 mg/day in divided doses. Initiating levodopa and amantadine concurrently, hold amantadine at 100 mg once or twice daily while gradually increasing levodopa. Prophylaxis or treatment of Influenza A symptoms: (Due to high resistance rates, amantadine is no longer recommended by the CDC for the treatment or prophylaxis of influenza A.) Adult: 100-200mg/day. Children > 10 years old or > 45 kg: 100mg BID. Children > 5 years old: 100mg QD.                                                                                                                                                                                                                                                                                                                     |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Contraindications  | Systemic fungal infection, hypersensitivity. Administration of live virus vaccine, unstable or infected joint, diagnosed sepsis.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Adverse Effects    | Common: Hypertension (Diabetic macular edema, 13%), Cushing's syndrome, Decreased body growth, Abnormal vision (1-9%), Cataract (Diabetic macular edema, 68%; retinal vein occlusion and uveitis, 5-54%), Conjunctival edema (5%), Conjunctivitis (6%), Corneal edema (Postoperative ocular inflammation and pain, 1% ; postoperative inflammation, 5-15%), Discomfort, Eye (10%), Disorder of anterior chamber of eye, Inflammation (10%), Dry eye syndrome (5%), Iridocyclitis, Iritis (5-15%), Raised intraocular pressure (Retinal vein occlusion and uveitis, 24-25% ; postoperative inflammation and pain, 5-15% ; ocular itching, 3% i), Vitreous floaters (1-5%), Depression, Euphoria, Pulmonary tuberculosis Serious: Cardiomyopathy, Rupture of ventricle due to acute myocardial infarction, Hyperglycemia, Hypokalemia, Pancreatitis, Infectious disease, Osteoporosis, Conjunctival hemorrhage (Diabetic macular edema, 23%; retinal vein occlusion and uveitis, 22%), Glaucoma (Diabetic macular edema, 1.2%), Keratitis (2%), Posterior subcapsular cataract, Retinal tear (2%), Retinal vascular disorder (3%), Uveitis (2%) |
| Pregnancy          | No Data                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Lactation          | No Data                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |

